Search Results - "Angelika Mehnert"

Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year by Fleischhacker, W. Wolfgang, Rabinowitz, Jonathan, Kemmler, Georg, Eerdekens, Mariëlle, Mehnert, Angelika

“…The extent to which antipsychotics improve patients' well-being is uncertain. To examine psychopathology and patient-rated functioning and well-being in…”
Get full text

Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden by Mehnert, Angelika, Nicholl, Deborah, Pudas, Hanna, Martin, Monique, McGuire, Alistair

“…To model the cost effectiveness of paliperidone palmitate (paliperidone long-acting injectable; PLAI), a new once-monthly long-acting antipsychotic therapy,…”
Get more information

To what extent do the PANSS and CGI-S overlap? by RABINOWITZ, Jonathan, MEHNERT, Angelika, EERDEKENS, Marielle

“…The Positive and Negative Symptom Scale (PANSS) and Clinical Global Impression (CGI-S) item for severity are used together to measure severity of psychotic…”
Get full text

Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology by Van Sanden, Suzy, Pisini, Marta, Duchesne, Inge, Mehnert, Angelika, Belsey, Jonathan

“…Background: The need to assess relative efficacy in the absence of comparative clinical trials is a problem that is often encountered in economic modeling. The…”
Get full text

A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service by Westerhout, Kirsten, Treur, Maarten, Mehnert, Angelika, Pascoe, Katie, Ladha, Imran, Belsey, Jonathan

“…Triple therapy using a protease inhibitor (PI) with peginterferon and ribavirin (PR) is increasingly used in patients with chronic hepatitis C virus (HCV)…”
Get more information

Health-related quality of life in Patients with schizophrenia during treatment with long-acting, injectable risperidone by NASRALLAH, Henry A, DUCHESNE, Inge, MEHNERT, Angelika, JANAGAP, Carmela, EERDEKENS, Mariëlle

“…We investigated the impact of treatment with long-acting, injectable risperidone versus placebo on health-related quality of life (HRQoL) in patients with…”
Get full text

A network meta-analysis to compare simeprevir with boceprevir and telaprevir in combination with peginterferon-α and ribavirin in patients infected with genotype 1 Hepatitis C virus by Taieb, Vanessa, Pacou, Maud, Ho, Sophia, Pettré, Ségolène, Van Sanden, Suzy, Pisini, Marta, Ustianowski, Andrew, Mehnert, Angelika

“…To conduct a network meta-analysis (NMA) to assess the relative efficacy and safety of simeprevir, a second generation oral protease inhibitor (PI), compared…”
Get more information

Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone by Lindenmayer, Jean-Pierre, Jarboe, Kathleen, Bossie, Cynthia A, Zhu, Young, Mehnert, Angelika, Lasser, Robert

“…Long-acting injectable antipsychotic formulations of conventional antipsychotics were developed to address the problem of partial adherence among patients with…”
Get full text

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany by Laux, Gerd, Heeg, Bart, van Hout, Ben A, Mehnert, Angelika

“…Schizophrenia is one of the most expensive psychiatric conditions because of high direct and indirect costs associated with the nature of the illness, its…”
Get full text

Objectivity in research in the pharmaceutical industry is possible by Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn

“…A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain…”
Get full text

Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis by De Graeve, Diana, Smet, Ann, Mehnert, Angelika, Caleo, Sue, Miadi-Fargier, Houda, Mosqueda, Guillermo Jasso, Lecompte, Damien, Peuskens, Joseph

“…Patients with schizophrenia suffer numerous relapses and rehospitalizations that are associated with high direct and indirect medical expense. Suboptimal…”
Get full text

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands by Caro, J Jaime, Salas, Maribel, Ward, Alexandra, Getsios, Denis, Mehnert, Angelika

“…The economic impact of dementia on the Dutch health and social services is substantial. To predict the long-term economic impact of galantamine, a…”
Get more information

Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for I year by FLEISCHHACKER, W. Wolfgang, RABINOWITZ, Jonathan, KEMMLER, Georg, EERDEKENS, Mariëlle, MEHNERT, Angelika

Get full text

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany: Costs and effects of the use of long-acting risperidone in the treatment of schizophrenia by LAUX, Gerd, HEEG, Bart M. S, VAN HOUT, Ben A, MEHNERT, Angelika

Get full text

Objectivity in research in the pharmaceutical industry is possible by Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn

Get full text

Objektive Forschung der Pharmaindustrie ist möglich by Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn

Get full text

Patient Satisfaction with Their Medication Increases during 1 Year of Treatment with Long-Acting Risperidone Injection by Carmela C. Janagap, Angelika Mehnert, Harald J. Freyberger, Inge Y. Duchesne

Get full text

Long-Acting, Injectable Risperidone: The First Long-Acting, Atypical Antipsychotic: Improves Quality of Life by Nasrallah, Henry A., Inge Y. Duchesne, Angelika Mehnert, Carmela C. Janagap

Get full text

Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia : a Belgian cost-effectiveness analysis: Costs and effects of the use of long-acting risperidone in the treatment of schizophrenia by DE GRAEVE, Diana, SMET, Ann, MEHNERT, Angelika, CALEO, Sue, MIADI-FARGIER, Houda, MOSQUEDA, Guillermo Jasso, LECOMPTE, Damien, PEUSKENS, Joseph

Get full text